CIK 0000908259
- Non-accelerated filer
- Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133679168
- Phone
- +1 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +400,000 | $0.03 | $13K | 91,444,217 |
| 2023-05-26 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +126,888 | $0.03 | $4K | 91,044,217 |
| 2023-05-02 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +100,000 | $0.05 | $5K | 90,917,329 |
| 2022-12-06 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +120,000 | $0.05 | $6K | 90,558,021 |
| 2022-11-22 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +70,000 | $0.08 | $6K | 90,438,021 |
| 2022-09-26 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +20,000 | $0.07 | $1K | 90,368,021 |
| 2022-08-25 | Trieu Vuong CHAIRMAN AND CEO | Purchase | +80,000 | $0.08 | $7K | 90,348,021 |
| 2020-11-24 | Shah Amit B. CHIEF FINANCIAL OFFICER | Purchase | +8,220 | $0.19 | $2K | 60,000 |
| 2020-11-23 | Shah Amit B. CHIEF FINANCIAL OFFICER | Purchase | +20,088 | $0.19 | $4K | 51,780 |
| 2020-11-20 | Shah Amit B. CHIEF FINANCIAL OFFICER | Purchase | +31,692 | $0.20 | $6K | 31,692 |
| 2020-11-19 | Park Chulho CHIEF TECHNOLOGY OFFICER | Purchase | +22,173 | $0.18 | $4K | 2,833,992 |
| 2020-11-19 | Trieu Vuong CHIEF EXECUTIVE OFFICER | Purchase | +50,500 | $0.19 | $10K | 15,812,308 |
| 2020-03-26 | Trieu Vuong CHIEF EXECUTIVE OFFICER | Purchase | +3,000 | $0.12 | $360 | 15,761,808 |
| 2018-04-12 | Reynolds Donald Rogers Director | Purchase | +250,000 | 280,000 | ||
| 2018-04-12 | Schwieterman William D President and CEO | Purchase | +625,000 | 625,747 | ||
| 2018-04-12 | LOAR MATTHEW M Chief Financial Officer | Purchase | +250,000 | 300,000 | ||
| 2016-12-16 | Reynolds Donald Rogers Director | Purchase | +12,700 | $0.34 | $4K | 12,700 |
| 2016-12-16 | Reynolds Donald Rogers Director | Purchase | +7,350 | $0.35 | $3K | 20,050 |
| 2016-12-16 | Reynolds Donald Rogers Director | Purchase | +9,950 | $0.36 | $4K | 30,000 |
| 2013-06-28 | LANGECKER PETER Chief Executive Officer | Purchase | +3,000 | $2.75 | $8K | 5,000 |
Page 2 of 8 · 141 trades